AtaiBeckley Inc. (ATAI) — AtaiBeckley announced its common stock was added to the Nasdaq Biotechnology Index (NBI), effective before the market open on December 22, 2025.
The index inclusion — a milestone that typically broadens passive-fund ownership — capped a year in which the company raised roughly $300 million, completed the atai–Beckley Psytech combination, and advanced BPL-003, VLS-01 and EMP-01 in Phase 2 development.
Source: globenewswire.com
For the rest of that week's sector news, read our week in review.